Literature DB >> 11751172

Induction of short heterodimer partner 1 precedes downregulation of Ntcp in bile duct-ligated mice.

Gernot Zollner1, Peter Fickert, Dagmar Silbert, Andrea Fuchsbichler, Conny Stumptner, Kurt Zatloukal, Helmut Denk, Michael Trauner.   

Abstract

Cholestasis is associated with retention of bile acids and reduced expression of the Na(+)/taurocholate cotransporter (Ntcp), the major hepatocellular bile acid uptake system. This study aimed to determine whether downregulation of Ntcp in obstructive cholestasis 1) is a consequence of bile acid retention and 2) is mediated by induction of the transcriptional repressor short heterodimer partner 1 (SHP-1). To study the time course for the changes in serum bile acid levels as well as SHP-1 and Ntcp steady-state mRNA levels, mice were subjected to common bile duct ligation (CBDL) for 3, 6, 12, 24, 72, and 168 h and compared with sham-operated controls. Serum bile acid levels were determined by radioimmunoassay. SHP-1 and Ntcp steady-state mRNA expression were assessed by Northern blotting. In addition, Ntcp protein expression was studied by Western blotting and immunofluorescence microscopy. Increased SHP-1 mRNA expression paralleled elevations of serum bile acid levels and was followed by downregulation of Ntcp mRNA and protein expression in CBDL mice. Maximal SHP-1 mRNA expression reached a plateau phase after 6-h CBDL (12-fold; P < 0.001) and preceded the nadir of Ntcp mRNA levels (12%, P < 0.001) by 6 h. In conclusion, bile acid-induced expression of SHP-1 may, at least in part, mediate downregulation of Ntcp in CBDL mice. These findings support the concept that downregulation of Ntcp in cholestasis limits intracytoplasmatic accumulation of potentially toxic bile acids.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11751172     DOI: 10.1152/ajpgi.00215.2001

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  19 in total

1.  A comparison of gene expression in mouse liver and kidney in obstructive cholestasis utilizing high-density oligonucleotide microarray technology.

Authors:  Gerald U Denk; Shi-Ying Cai; Wen-Sheng Chen; Aiping Lin; Carol J Soroka; James L Boyer
Journal:  World J Gastroenterol       Date:  2006-04-28       Impact factor: 5.742

2.  Hepatoprotection in bile duct ligated mice mediated by darbepoetin-α is not caused by changes in hepatobiliary transporter expression.

Authors:  Christian Eipel; Elena Menschikow; Michael Sigal; Angela Kuhla; Kerstin Abshagen; Brigitte Vollmar
Journal:  Int J Clin Exp Pathol       Date:  2012-11-20

3.  Sustained upregulation of sodium taurocholate cotransporting polypeptide and bile salt export pump and downregulation of cholesterol 7α-hydroxylase in the liver of patients with end-stage primary biliary cirrhosis.

Authors:  Yasuaki Takeyama; Kazuko Kanegae; Shinjiro Inomata; Kazuhide Takata; Takashi Tanaka; Shu-Ichi Ueda; Keiji Yokoyama; Daisuke Morihara; Shinya Nishizawa; Akira Anan; Makoto Irie; Kaoru Iwata; Satoshi Shakado; Tetsuro Sohda; Shotaro Sakisaka
Journal:  Med Mol Morphol       Date:  2010-09-21       Impact factor: 2.309

Review 4.  Inflammation and Cell Death During Cholestasis: The Evolving Role of Bile Acids.

Authors:  Benjamin L Woolbright; Hartmut Jaeschke
Journal:  Gene Expr       Date:  2019-06-28

5.  Hepatocyte-specific ablation of Foxa2 alters bile acid homeostasis and results in endoplasmic reticulum stress.

Authors:  Irina M Bochkis; Nir E Rubins; Peter White; Emma E Furth; Joshua R Friedman; Klaus H Kaestner
Journal:  Nat Med       Date:  2008-07-27       Impact factor: 53.440

6.  Overexpression of sterol carrier protein-2 differentially alters hepatic cholesterol accumulation in cholesterol-fed mice.

Authors:  Barbara P Atshaves; Avery L McIntosh; Gregory G Martin; Danilo Landrock; H Ross Payne; Shivaprasad Bhuvanendran; Kerstin K Landrock; Olga I Lyuksyutova; Jeffery D Johnson; Ronald D Macfarlane; Ann B Kier; Friedhelm Schroeder
Journal:  J Lipid Res       Date:  2009-03-16       Impact factor: 5.922

7.  Role of hepatic transporters in prevention of bile acid toxicity after partial hepatectomy in mice.

Authors:  Iván L Csanaky; Lauren M Aleksunes; Yuji Tanaka; Curtis D Klaassen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-06-04       Impact factor: 4.052

Review 8.  Bile acid transporters.

Authors:  Paul A Dawson; Tian Lan; Anuradha Rao
Journal:  J Lipid Res       Date:  2009-06-04       Impact factor: 5.922

9.  Regulation of hepatic bile acid transporters Ntcp and Bsep expression.

Authors:  Xingguo Cheng; David Buckley; Curtis D Klaassen
Journal:  Biochem Pharmacol       Date:  2007-08-19       Impact factor: 5.858

Review 10.  Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Authors:  Curtis D Klaassen; Lauren M Aleksunes
Journal:  Pharmacol Rev       Date:  2010-01-26       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.